Change in cerebrospinal fluid (CSF) Tau levels, pulse wave velocity (PWV), augmentation index (AI), brain perfusion, hippocampal volume, vasoreactivity, clinical dementia rating (CDR). This evidence concerns the gene MAPT and dementia.